2023 EULAR Recommendations on Imaging in Diagnosis and Management of Crystal-induced Arthropathies in Clinical Practice
Overview
Authors
Affiliations
Objective: To formulate evidence-based recommendations and overarching principles on the use of imaging in the clinical management of crystal-induced arthropathies (CiAs).
Methods: An international task force of 25 rheumatologists, radiologists, methodologists, healthcare professionals and patient research partners from 11 countries was formed according to the EULAR standard operating procedures. Fourteen key questions on the role of imaging in the most common forms of CiA were generated. The CiA assessed included gout, calcium pyrophosphate deposition disease and basic calcium phosphate deposition disease. Imaging modalities included conventional radiography, ultrasound, CT and MRI. Experts applied research evidence obtained from four systematic literature reviews using MEDLINE, EMBASE and CENTRAL. Task force members provided level of agreement (LoA) anonymously by using a Numerical Rating Scale from 0 to 10.
Results: Five overarching principles and 10 recommendations were developed encompassing the role of imaging in various aspects of patient management: making a diagnosis of CiA, monitoring inflammation and damage, predicting outcome, response to treatment, guided interventions and patient education. Overall, the LoA for the recommendations was high (8.46-9.92).
Conclusions: These are the first recommendations that encompass the major forms of CiA and guide the use of common imaging modalities in this disease group in clinical practice.
Editorial: Calcium pyrophosphate deposition disease.
Filippou G, Dalbeth N, Tedeschi S Front Med (Lausanne). 2025; 12:1557035.
PMID: 39950127 PMC: 11821655. DOI: 10.3389/fmed.2025.1557035.
Ultrasonography in the assessment of calcium pyrophosphate deposition disease.
Yinh J, Jarraya M, Guermazi A Skeletal Radiol. 2025; .
PMID: 39918638 DOI: 10.1007/s00256-025-04883-9.
Advanced imaging techniques in crystal arthritis.
Laurent V, Filippou G, Sirotti S, Pascart T Ther Adv Musculoskelet Dis. 2025; 17:1759720X251316097.
PMID: 39906218 PMC: 11792016. DOI: 10.1177/1759720X251316097.
Imaging and management of calcium pyrophosphate deposition disease.
Issa W, Mercer R, Yinh J, Guermazi A, Jarraya M Skeletal Radiol. 2025; .
PMID: 39775910 DOI: 10.1007/s00256-024-04859-1.
The comprehensive role of dual-energy CT in gout as an advanced diagnostic innovation.
Fukuda T, Subramanian M, Noda K, Kumeta S, Mori H, Ikeda N Skeletal Radiol. 2024; .
PMID: 39690304 DOI: 10.1007/s00256-024-04856-4.